ArticleJournal of translational medicine2024

Manufacturing mesenchymal stromal cells in a microcarrier-microbioreactor platform can enhance cell yield and quality attributes: case study for acute respiratory distress syndrome.

Brandon Krupczak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.